Compliance, infrastructure, and operating wisdom for medical wellness businesses — from the physicians and operators who do this every day.
An NP cannot independently own a California med spa the way a physician can — but the MSO-PC structure makes compliant NP-led ownership possible when built correctly.
With the FDA's July 2026 advisory committee meeting approaching, peptide compounding may reopen. Here's the real regulatory timeline and what clinics need in place before offering peptide therapy.
Peptides are having their moment. Here's what the science actually shows about BPC-157, TB-500, and CJC-1295/Ipamorelin — and what clinics should and shouldn't claim.
The regulatory momentum around peptides is real. Here's how to build a peptide program that actually lasts — from medical director oversight to compliant sourcing and marketing.
Patient acquisition costs have doubled since 2023. Here's the strategy behind the tasks — compliance-first marketing, high-intent search, and the conversion infrastructure that turns ad spend into booked patients.
Standing orders are the documented mechanism through which a physician extends clinical authority to other licensed practitioners. Here's what they must include — and why they're only as good as the physician behind them.